PHX
PHARMX FPO [PHX]
Healthcare · ASX Small Cap
$0.0880 +0.0%
Updated 3 Sep 2026 · Signals refresh every scan
Appeared in 3 consecutive scansFirst seen: 2026-02-25
Get alerts when PHX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI is looking oversold — historically a spot where stocks tend to bounce
- MACD momentum is losing steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
- Volume surging at 5.5x normal while price falls — heavy selling pressure
- Took a hit — down 12.0% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.90, underperforming its peers
- Volatility is expanding fast — choppy price action, so buckle up
- Cash positive / operating cashflow positive
- Moderate P/S ratio (7.4x)
- Moderate revenue growth (+5%)
- Near 52-week low (1% of range)
- Small-cap ($20-100M)
- CANSLIM S: Tight float (45%)
- Sentiment is mixed — no strong consensus either way
- The bigger volume days are the up days — volume-weighted momentum is positive (1.17%/day)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Deeply negative margins (-24%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 33% over the past year
Ask Scout AI about PHX
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE FY26 Results Presentation
NONE Announcement of FY26 Results
NONE Appendix 4G & FY26 Corporate Governance Statement
LOW Appendix 4E & FY26 Annual Report
Recent ASX Announcements
| 2026-08-26 | FY26 Results Presentation PRICE SENSITIVE |
| 2026-08-26 | Announcement of FY26 Results PRICE SENSITIVE |
| 2026-08-26 | Appendix 4G & FY26 Corporate Governance Statement |
| 2026-08-26 | Appendix 4E & FY26 Annual Report PRICE SENSITIVE |
| 2026-08-20 | Notice of FY26 Results Announcement |
Key Metrics
$56.6M
Market Cap
177K
Avg Volume
5.5x
Vol Ratio
$0.08 — $0.20
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-9.3%
ROE
-24.0%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 45% |
| L | Leader vs Laggard | laggard | RS: -13 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
113 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track PHX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required